TABILIO, Antonio
 Distribuzione geografica
Continente #
NA - Nord America 2.888
EU - Europa 2.220
AS - Asia 1.931
SA - Sud America 305
AF - Africa 52
Continente sconosciuto - Info sul continente non disponibili 4
OC - Oceania 4
Totale 7.404
Nazione #
US - Stati Uniti d'America 2.840
SG - Singapore 880
UA - Ucraina 454
IE - Irlanda 341
SE - Svezia 333
CN - Cina 273
RU - Federazione Russa 262
BR - Brasile 236
VN - Vietnam 225
HK - Hong Kong 213
DE - Germania 202
FI - Finlandia 151
IT - Italia 151
GB - Regno Unito 115
FR - Francia 110
KR - Corea 101
TR - Turchia 45
IN - India 42
BD - Bangladesh 32
AR - Argentina 26
CA - Canada 21
JP - Giappone 18
IQ - Iraq 17
UZ - Uzbekistan 17
MX - Messico 16
AT - Austria 15
ZA - Sudafrica 15
CH - Svizzera 12
BE - Belgio 10
CO - Colombia 10
CZ - Repubblica Ceca 10
MA - Marocco 10
PK - Pakistan 10
PL - Polonia 10
EC - Ecuador 9
NL - Olanda 9
CL - Cile 8
GR - Grecia 8
AZ - Azerbaigian 7
LB - Libano 7
PY - Paraguay 7
SA - Arabia Saudita 7
ES - Italia 6
ID - Indonesia 6
RO - Romania 6
TN - Tunisia 6
VE - Venezuela 6
EG - Egitto 5
ET - Etiopia 5
OM - Oman 5
PH - Filippine 5
JO - Giordania 4
KE - Kenya 4
LT - Lituania 4
AU - Australia 3
BO - Bolivia 3
DO - Repubblica Dominicana 3
DZ - Algeria 3
EU - Europa 3
IL - Israele 3
MY - Malesia 3
TT - Trinidad e Tobago 3
AL - Albania 2
JM - Giamaica 2
PS - Palestinian Territory 2
QA - Qatar 2
AE - Emirati Arabi Uniti 1
BF - Burkina Faso 1
BG - Bulgaria 1
CM - Camerun 1
DK - Danimarca 1
EE - Estonia 1
GE - Georgia 1
GH - Ghana 1
GT - Guatemala 1
HN - Honduras 1
HR - Croazia 1
IS - Islanda 1
KG - Kirghizistan 1
KZ - Kazakistan 1
LV - Lettonia 1
LY - Libia 1
MD - Moldavia 1
ME - Montenegro 1
NP - Nepal 1
NR - Nauru 1
PT - Portogallo 1
SV - El Salvador 1
SY - Repubblica araba siriana 1
XK - ???statistics.table.value.countryCode.XK??? 1
YE - Yemen 1
Totale 7.404
Città #
Singapore 626
Chandler 427
Dublin 341
Jacksonville 247
San Mateo 243
San Jose 221
Hong Kong 213
Ashburn 180
Boardman 132
Dong Ket 115
Seoul 101
Santa Clara 94
Beijing 83
Medford 79
Princeton 78
Ann Arbor 77
Moscow 72
Lauterbourg 66
Wilmington 63
Andover 59
Helsinki 49
Los Angeles 47
Munich 40
Piscataway 40
New York 37
Altamura 33
Shanghai 33
Ho Chi Minh City 32
Lawrence 32
Woodbridge 29
Perugia 25
Izmir 23
Hanoi 21
Houston 21
Saint Petersburg 21
Turku 21
Norwalk 18
The Dalles 17
Tokyo 17
Auburn Hills 16
Des Moines 16
São Paulo 15
Orem 14
Falkenstein 13
Dallas 12
Johannesburg 12
Brooklyn 11
Council Bluffs 11
Brussels 10
Foligno 10
Redwood City 10
Chennai 9
Denver 9
London 9
Rio de Janeiro 9
Tashkent 9
Phoenix 8
San Paolo di Civitate 8
Ankara 7
Baku 7
Brno 7
Chicago 7
Falls Church 7
Frankfurt am Main 7
Philadelphia 7
Baghdad 6
Charlotte 6
Dhaka 6
Haiphong 6
Lahore 6
New Delhi 6
Addis Ababa 5
Belo Horizonte 5
Bexley 5
Boston 5
Brasília 5
Curitiba 5
Da Nang 5
Dearborn 5
Montreal 5
Rome 5
San Francisco 5
Toronto 5
Warsaw 5
Amsterdam 4
Asunción 4
Barnet 4
Memphis 4
Mexico City 4
Ottawa 4
Piediluco 4
Quito 4
Ribeirão Preto 4
Roubaix 4
Stockholm 4
Tunis 4
Bogotá 3
Bologna 3
Buenos Aires 3
Calarasi 3
Totale 4.494
Nome #
Advances in full-haplotype mismatched transplants in acute leukemia 182
Sovraccarico di ferro in pazienti affetti da linfoma non Hodgkin (LNH) sottoposti a trapianto di midollo osseo autologo (A-TMO) ed emocromatosi ereditaria: esiste correlazione? Atti del IX Congresso Nazionale S.I.G.U. 182
Engineering donor mesenchymal cells with IL-7 hastens naive T cell recruitment. 169
B-chronic lymphocytic leukemia cells exert an in vitro cytotoxicity mediated by tumor necrosis factor alpha. 167
Activated autologous T cells exert an anti-B-cell chronic lymphatic leukemia effect in vitro and in vivo. 150
Engineering donor mesenchymal cells with IL-7 hastens naive T cell recruitment in vitro and supports immunologic reconstitution after HSCT in NOD/SCID mice 143
Apoptosis of human primary B lymphocytes is inhibited by N-acetyl-L-cysteine 140
Graft engineering for allogeneic haploidentical stem cell transplantation 134
Constitutively activated Notch signaling is involved in survival and apoptosis resistance of B-CLL cells. 134
. G-CSF blocks IL-12 productin by antigen presenting cells: implications for improved immune reconstitution after haploidentical hematopoietic transplantation. 129
G-CSF blocks IL-12 production by antigen presenting cells: implications for improved immune reconstitution after haploidentical hematopoietic transplantation.. 128
Fourth international workshop on haploidentical transplants, Naples, Italy 125
Mesenchymal cells: a vehicle for gene therapy 123
Modulating the gene silencing: novel insights to overcame gene therapy major limitation also in orthopaedic applications. 122
Recruitment of beta-hexosaminidase activity on plasma membrane and human T-cell activation-52° Congresso SIB 119
Chronic myeloproliferative disorders: the bone marrow stromal component is not involved in the malignant clone.Di Ianni M, Moretti L, Del Papa B, De Ioanni M, Bonifacio E, Falzetti F, Tabilio A. 118
Full haplotype-mismatched hematopoietic stem-cell transplantation: A phase II study in patients with acute leukemia at high risk of relapse 117
Addition of PBPCs to the marrow inoculum allows engraftment of mismatched T cell-depleted transplants for acute leukemia 116
Human stromal cells engineered with interleukin-7 enhance the survival of naive T lymphocytes. 115
Engineering mesenchymal cells with interleukin 7 gene: effects on T cell. 18-23. 115
Characterization of a Unique Cd133+ Leukemia Cell Line Responsive to FGF2 and TGFb1 113
Plasma membrane associated beta-hexosaminidase activity increases during human T-cells activation 112
Decreased bone mineral density after autologous stem cell transplantation. 107
Histone deacetylation in retroviral driven transgene silencing: role of TSA as a pharmacological support for gene therapy 106
Allogeneic transplantation across the HLA barriers. 105
Interleukin-7-engineered mesenchymal cells: in vitro effects on naive T-cell population. 105
Transplants across human leukocyte antigen barriers 104
New perspectives in haematopoietic stem cell transplantation. Transplantation across HLA barriers. 103
Characterization of a unique CD133+leukemia cell line responsive to FGF2 and TGFbeta1 103
Characterization of human lysosomal α-D-mannosidase in leukaemic and non leukaemic cells 102
A microelectronic DNA chip detects the V617F JAK-2 mutation in myeloproliferative disorders 102
. Mismatched hematopoietic stem cell transplants in elderly patients. 102
Raccolta dei progenitori emopoietici circolanti allogenici con separatore cellulare a flusso discontinuo. . 101
Cataracts in patients receiving stem cell transplantation after conditioning with total body irradiation 100
Effect of trichostatin a and 5'-azacytidine on transgene reactivation in U937 transduced cells 100
Stem cell mobilization in normal donors. 95
Haploidentical stem cell transplantation for acute leukemia 92
Full-haplotype mismatched HSCT for high risk acute myeloid leukemia (AML). 92
Mismatched hematopoietic stem cell transplantation in secondary leukemia 91
A comprehensive genetic classification of adult acute lymphoblastic leukemia (ALL): analysis of the GIMEMA 0496 protocol 91
A mature thymocyte-like phenotypic pattern on human cord circulating T-lymphoid cells. 90
Striking survival advange of bad-risk acute myeloid leukemia patients transplanted from haploidentical donors with KIR epitope incompatibility in the GVH direction 90
High efficient gene transfer transduction using herpes simplex virus thymidine kinase (HSV-TK) gene: a comparison of different infection protocols. 86
Unique human CD133+ leukemia cell line and its modulation towards a mesenchymal phenotype by FGF2 and TGFbeta1 86
Hematopoietic stem cell transplantation (HSCT) from alternative donors for acute leukemia at high-risk of relapse. the haploidentical option. 85
Transformation by retroviral vectors of bone marrow-derived mesenchymal cells induces mitochondria-dependent cAMP-sensitive reactive oxygen species production. 85
Immunomagnetic isolation of CD4+CD25+FoxP3+ natural T regulatory lymphocytes for clinical applications. 84
Postgrafting administration of granulocyte colony-stimulating factor impairs functional immune recovery in recipients of human leukocyte antigen haplotype-mismatched hematopoietic transplants 83
Mesenchymal cells recruit and regulate T regulatory cells. 83
Treating two concurrent B-cell and T-cell lymphoid neoplasms with alemtuzumab monotherapy 81
Large-scale preparation of human anti-third-party veto cytotoxic T lymphocytes depleted of graft-versus-host reactivity: a new source for graft facilitating cells in bone marrow transplantation. 81
Full haplotype mismatched transplant in high risk acute leukemia patients. 80
IL-7 engineered donor stromal cells in vitro: a new approach for hastening naive T cell recruitment. 79
Diagnostic considerations on visceral leishmaniasis. Two case reports 79
Loss of bone mineral density and secondary hyperparathyroidism are complications of autologous stem cell transplantation. 79
Immune regulatory activity of CD34+ progenitor cells: evidence for a deletion based mechanism mediated by TNF-{alpha} 78
Full-haplotype mismatched HSCT is a valid option for high-risk acute myeloid leukemia (AML) patients. 78
Hematopoietic stem cell transplantation from alternative donors for high-risk acute leukemia: the haploidentical option. 77
Stem cell transplantation from full-haplotype mismatched donors in leukemia . 76
Homing and survival of thymidine kinase-transduced human T cells in NOD/SCID mice 76
Successful engraftment of T-cell-depleted haploidentical "three-loci" incompatible transplants in leukemia patients by addition of recombinant human granulocyte colony-stimulating factor-mobilized peripheral blood progenitor cells to bone marrow inoculum. 75
Non-B, non-T acute lymphoblastic leukaemia terminating in malignant histiocytosis: a new case and a review of the literature. 74
Implicazione della deacetilazione degli istoni nel silenziamento di transgeni veicolati tramite vettori retrovirali: ipotetico ruolo del TSA come supporto della terapia genica. 73
HSV-TK gene as a potential tool for gene generating a controlled graft-versus-host/graft-versus-leukemia effect 73
Outcomes after CD34+ positive immunoselection for haploidentical transplants in high-risk acute leukemia. 71
T-lymphocyte function after retroviral-mediated thymidine kinase gene transfer and G418 selection. 67
High frequency of clonal immunoglobulin or T cell receptor gene rearrangements in acute myelogenous leukemia expressing terminal deoxyribonucleotidyltransferase. 67
In vivo demethylation of a MoMuLV retroviral vector expressing the herpes simplex thymidine kinase suicide gene by 5' azacytidine. 65
Primary eyelid plasmacytoma. 64
Eradication of B-CLL by Autologous and Allogeneic Host Non-Reactive Anti-Third Party CTLs. 62
The in vivo effect of thymic factor (thymostimulin) administration on circulating immune complexes and serum lysozyme levels in untreated Hodgkin's disease patients. 61
Haematopoietic and Stromal Stem Cell Regulation by Extracellular Matrix Components and Growth Factors 59
Hematopoietic stem cell transplantation from alternative donors for high-risk acute leukemia: the haploidentical option. 59
Homing and survival of thymidine kinase transduced T-limphocytes into NOD/SCID mice. 56
Homing and survival of thimidine kinase transduced human T-cells in NOD/SCID mice. 55
Haploidentical stem cell transplantation in leukemia 54
Results of a prospective study with high-dose etoposide, thiotepa and carboplatin and peripheral blood stem cell rescue for high-risk stage II-IIIA and selected stage IV breast cancer patients. 52
Interleukin 7 retroviral gene transfer in human stromal cells enhances the survival of naive T lymphocyte. . 52
Totale 7.529
Categoria #
all - tutte 28.979
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 28.979


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021250 0 0 0 0 0 0 0 0 0 34 87 129
2021/2022774 18 196 32 71 33 6 10 217 3 7 94 87
2022/20231.200 87 161 3 122 98 141 0 60 476 3 30 19
2023/2024443 27 47 30 4 1 9 101 24 56 13 46 85
2024/20251.079 24 118 26 56 183 25 21 78 193 71 184 100
2025/20262.233 172 163 124 304 299 235 410 111 240 175 0 0
Totale 7.529